Le Lézard
Classified in: Health
Subjects: FDA, IMA

EndoFresh Obtains FDA 510(k) Clearance for Its Groundbreaking Disposable Digestive Endoscopy System


STATEN ISLAND, N.Y., May 24, 2021 /PRNewswire/ -- The FDA has greenlighted EndoFresh Disposable Digestive Endoscopy System, following years of reports of persistent cross-contamination issues being transmitted among multi-patients by the notoriously difficult-to-clean devices and efforts earlier this year to urge the industry to transform devices into safer design without reprocessing. EndoFresh Disposable Digestive Endoscopy System features a camera system with innovative all-in-one design, disposable upper GI endoscope and disposable colonoscope, which are used together with the medical display and other peripheral devices to allow physicians to visualize, diagnose and operate gastrointestinal endoscopy.

Recently, the FDA has alerted health care providers to the risk of infections associated with reprocessed urological endoscopes, citing over 450 medical device reports since 2017, describing post-procedure patient infections or other possible contamination. According to the agency statement, the problems identified with reprocessed urological endoscopes and duodenoscopes may apply to similar devices. Therefore, the FDA has also been reviewing information on other types of reusable endoscopes.

Since the global flexible endoscope market blossoming for safety and effectiveness, many manufacturers have engaged in the R&D of disposable endoscope. EndoFresh's industry-pioneering technology addresses the traditional challenge of expanding endoscopy procedures, while ensuring its single-use devices are cost-effective, risk-controllable and accessible. "With this novel system, medical practitioners could offer patients a secure experience, which is available at anytime and anywhere. It helps to prevent the risk of cross-infection and minimize the workload in preoperative screening and postoperative disinfection," said EndoFresh CEO, Dr. Lee.

Compared with high acquisition and repair expenses, spending on washing equipment and cleaning personnel as well as multiple points of failure associated with improper high-level disinfection practices of reusable endoscope, the risk factor of disposable endoscope is much lower or even negligible. EndoFresh differentiates its devices from traditional reprocessing and time-consuming maintenance solutions, while also adhering to strict reliability and first-class quality standards and adapting to the fast-growing market demands for innovation and possessing greater potential to generate actual benefits in the near future.

About EndoFresh

Established in 2014, EndoFresh is a Chinese high-tech medical device manufacturing enterprise engaged in R&D and manufacture of high-end disposable digestive endoscopes. Headquartered in Shenzhen Science Park, one of the most dynamic innovation centers in China, EndoFresh independent R & D products have obtained over 200 patents. Moreover, the company is manufactured in compliance with the ISO 13485 certificate. EndoFresh are dedicated to make every endoscopy no-delay, risk-free and cost-effective process.

For more information, please visit www.endofresh.com

Related Images

endofresh-disposable-gi-endoscope.jpg
EndoFresh Disposable GI Endoscope and Colonoscope

SOURCE EndoFresh


These press releases may also interest you

at 00:01
U.S. News & World Report, the global authority in hospital rankings and consumer advice, today debuted the Best Ambulatory Surgery Centers ratings of outpatient surgical centers....

at 00:00
Butterfly Play LLC is dedicated to enhancing the mental and emotional development of children through personalized play skill...

at 00:00
Amygdala Neurosciences (a private company) announced today that the Company has closed a new round of equity financing led by ABMRF, the Alcohol Beverage Medicines Research Foundation to fund the Company's IND-stage activities for ANS-858....

at 00:00
Pvolve, the fitness franchise that pairs low-impact, functional movement with resistance equipment to build strong, mobile bodies, is heading to San Francisco, following the franchise's latest development deal for two new studios in the Bay Area with...

13 mai 2024
Allozymes, a leading innovator in enzyme discovery and engineering, today announced the closing of a $15 million Series A funding round led by Seventure Partners of France and Xora Innovation of Singapore. This significant investment underscores the...

13 mai 2024
Frito Lay Canada today announced that out of an abundance of caution it is voluntarily recalling SunChips Harvest Cheddar Flavour Multigrain Snacks and Munchies Original Snack Mix. This action is the direct result of a seasoning supplier's...



News published on and distributed by: